ABBOTT PARK, Ill., Nov. 30, 2016
/PRNewswire/ -- Abbott (NYSE: ABT) announced today its
i-STAT® Alinity™ System, an innovative, handheld blood
testing platform, received CE Mark and is now for sale in
Europe and other countries that
recognize CE Mark. The portable device can perform and analyze the
largest menu of blood tests on a single device, ranging from blood
chemistries to cardiac markers, using only two to three drops of a
person's blood.1 Delivering results in two to 10
minutes, i-STAT Alinity equips healthcare professionals with the
information they need to make fast and accurate medical decisions
without ever leaving their patient's side. Its advanced
connectivity features allow testing to be conducted virtually
anywhere.
"As a global leader in point of care testing, Abbott's i-STAT
Alinity builds on our rich diagnostics heritage to help healthcare
providers deliver care when and where it's needed," said
Sharon Bracken, vice president,
Point of Care Diagnostics, Abbott. "Whether in emergency
departments, critical care settings or rural areas, i-STAT Alinity
allows clinicians to make timely and informed treatment decisions
that help people get back to better health."
Globally, demand for healthcare is growing as people live
longer, chronic diseases are more prevalent and people are more
involved in decisions pertaining to their health. As more people
access care, health systems, hospitals and other clinical care
settings are challenged to keep pace and find resourceful,
efficient and cost-effective ways to provide quality
care.
To address these needs, Abbott developed i-STAT Alinity to be
intelligent, intuitive and easy to use, empowering healthcare
professionals to provide high-quality care for people across the
globe. First-of-its kind, patented features include:
- Expansive testing menu capabilities to enable the most
combinations of tests in a single cartridge and new types of tests
in the future, including tests for brain injury, infectious disease
and oncology
- Advanced quality control features designed with patient safety
and regulatory compliance in the forefront
- Wireless or hard-wired connectivity so healthcare providers can
manage diagnostic data and oversight with the broader healthcare
system's network
- Cloud connectivity that uses a standard web browser, making it
easy for health systems to customize multiple i-STAT Alinity
instruments and provide seamless transmission of quality control
data
- A large, bright, color touchscreen with graphics-driven,
on-screen guidance and advanced light and sound notifications that
alert clinicians with critical information
- An ergonomic design with easy-grip handling that is balanced,
comfortable and secure
- Durable materials designed to prevent damage from drops and
harsh cleaning substances commonly used in clinical settings
In today's pressure-packed healthcare environment, clinicians
rely on easy-to-use testing technologies that do not require
complex training. Innovative point of care testing tools like
Abbott's i-STAT Alinity can help address this need and provide a
simpler experience for those who use it, allowing them to
accurately diagnose and treat patients faster and more
efficiently.
DESIGNED WITH CUSTOMER-DRIVEN INSIGHTS
To better understand customer needs, Abbott sent cross-functional
teams to visit administrators, clinicians and laboratory
professionals to gain specific insights on the experiences and
challenges healthcare providers face day-to-day with point of care
testing.
"We spent countless hours doing on-the-ground research with
doctors, nurses, lab directors, point of care coordinators and
other customers from around the world. We asked about their pain
points and listened to what they want and need for testing," said
Matt Bates, divisional vice
president, research and development, Point of Care Diagnostics,
Abbott. "Using these customer insights, Abbott designed and built
i-STAT Alinity for better access, efficiency and speed to improve
clinical decision making and positively impact patients'
lives."
i-STAT Alinity is the first of several next-generation
instruments Abbott will launch as part of its harmonized family of
Alinity systems across point of care, immunoassay, clinical
chemistry, hematology, blood and plasma screening and molecular
diagnostics. To learn more about Abbott's i-STAT Alinity, visit
www.abbott.com/newsroom/news.html. Healthcare providers can find
more information at
https://www.abbottpointofcare.com/i-stat-alinity-ce.
About Abbott:
At Abbott, we're committed to helping you live your best possible
life through the power of health. For more than 125 years, we've
brought new products and technologies to the world—in nutrition,
diagnostics, medical devices and branded generic
pharmaceuticals—that create more possibilities for more people at
all stages of life. Today, 74,000 of us are working to help people
live not just longer, but better, in the more than 150 countries we
serve.
Connect with us at www.abbott.com, on Facebook at
www.facebook.com/Abbott and on Twitter @AbbottNews and
@AbbottGlobal.
1 i-STAT Alinity is launching with a comprehensive
test menu, including blood gases, chemistries, electrolytes and
hematology. Commercial availability of cartridges may vary
depending on geographic locations. Cardiac markers, coagulation and
other tests will be available at a later date.
Logo - http://photos.prnewswire.com/prnh/20150928/271488LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/abbott-announces-ce-mark-for-i-stat-alinity-a-pioneering-handheld-blood-testing-platform-300370020.html
SOURCE Abbott